Dayuha, Nimfa L.
HRN: 23-01-74 Sex: FemalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/12/2023
CEFUROXIME 500MG (TAB)
05/12/2023
05/19/2023
PO
500mg
BID
Episiorraphy
Waiting Final Action